The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion
Open accessAbstract
Study objective To demonstrate the efficacy, safety, and appropriate mode of instillation of talc for sclerosis in treatment of malignant pleural effusions (MPEs).Design A prospective, randomized trial was designed to compare thoracoscopy with talc insufflation (TTI) to thoracostomy and talc slurry (TS) for patients with documented MPE.Measurements The primary end point was 30-day freedom from radiographic MPE recurrence among surviving patients whose lungs initially re-expanded > 90%. Morbidity, mortality, and quality of life were also assessed.Results Of 501 patients registered, those eligible were randomized to TTI (n = 242) or TS (n = 240). Patient demographics and primary malignancies were similar between study arms. Overall, there was no difference between study arms in the percentage of patients with successful 30-day outcomes (TTI, 78%; TS, 71%). However, the subgroup of patients with primary lung or breast cancer had higher success with TTI than with TS (82% vs 67%). Common morbidity included fever, dyspnea, and pain. Treatment-related mortality occurred in nine TTI patients and seven TS patients. Respiratory complications were more common following TTI than TS (14% vs 6%). Respiratory failure was observed in 4% of TS patients and 8% of TTI patients, accounting for five toxic deaths and six toxic deaths, respectively. Quality-of-life measurement demonstrated less fatigue with TTI than TS. Patient ratings of comfort and safety were also higher for TTI, but there were no differences on perceived value or convenience of the procedures.Conclusions Both methods of talc delivery are similar in efficacy; TTI may be better for patients with either a lung or breast primary. The etiology and incidence of respiratory complications from talc need further exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“thoracoscopic insufflation with talc ( poudrage) is more effective than talc slurry sclerosis [II, B] [145].”
From Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2016) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Self-citationChemical Pleurodesis for Malignant Pleural Effusions
Walker-Renard, P., Vaughan, L. M., & Sahn, S. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00010 · Cited by 420
de Campos, J. R. M., Cardoso, P. F. G., Vargas, F. S., Werebe, E. D. C., Teixeira, L. R., Jatene, F. B., & Light, R. W. (2001) · CHEST Journal · doi:10.1378/chest.119.3.801 · Cited by 284
Talc Pleurodesis for the Treatment of Pneumothorax and Pleural Effusion
Kennedy, L., & Sahn, S. A. (1994) · CHEST Journal · doi:10.1378/chest.106.4.1215 · Cited by 262
Respiratory failure following talc pleurodesis
Rehse, D. H., Aye, R. W., & Florence, M. G. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00075-6 · Cited by 252
Kennedy, L., Rusch, V. W., Strange, C., Ginsberg, R. J., & Sahn, S. A. (1994) · CHEST Journal · doi:10.1378/chest.106.2.342 · Cited by 247
Thoracoscopic Talc Poudrage Pleurodesis for Malignant Effusions
Viallat, J. R., Rey, F., Astoul, P. J., & Boutin, C. (1996) · CHEST Journal · doi:10.1378/chest.110.6.1387 · Cited by 240
Adult respiratory distress syndrome following intrapleural instillation of talc
Rinaldo, J. E., Owens, G. R., & Rogers, R. M. (1983) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37535-x · Cited by 221
Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion
Yim, A. P. C., Chan, A. T. �., Tak, W. L., Wan, I. Y. P., & Ho, J. K. (1996) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)00808-9 · Cited by 217
Predicting Survival in Patients With Recurrent Symptomatic Malignant Pleural Effusions
Burrows, C. M., Mathews, W. C., & Colt, H. G. (2000) · CHEST Journal · doi:10.1378/chest.117.1.73 · Cited by 203
Flagged first, then by citations
Research works printed but not linked: 2
- 1958, West J Surg Obstet Gynecol, 66, 26
- Fleishman, 2002, Quality of life (QOL) advantage of sclerosis for malignant pleural effusion (MPE) via talc thoracoscopy over chest tube infusion of talc slurry: a Cancer and Leukemia Group B study [abstract], Proc Am Soc Clin Oncol, 21, 355a
Cited by
Sorted by citations
Items 401–500 of 577
Factors Affecting Rate of Pleural Fluid Accumulation in Patients with Malignant Pleural Effusions
Sethi, D., Kouritas, V. K., & Mishra, E. K. (2023) · Current Pulmonology Reports · doi:10.1007/s13665-023-00299-9 · Cited by 2
Benign and Malignant Pleural Effusions
Schneider, T. (2014) · Springer eBooks · doi:10.1007/978-3-642-12044-2_36 · Cited by 2
The Pathway to Definitive Palliation of Malignant Pleural Effusions
Shieh, B., Beaudoin, S., & Gonzalez, A. V. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201811-770rl · Cited by 2
Campion, E., Mallah, S. I., Azhar, M., O’Keeffe, D., & Hameed, A. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102697 · Cited by 2
“The decision for the use of talc poudrage or talc slurry depends on multiple factors, with talc slurry being less invasive than talc poudrage, in which the thoracoscopy procedure can cause complications, such as atelectasis, pneumonia, or respiratory failure [7, 14].”
BackgroundApport de l’imagerie par tomographie à émission de positons dans la pathologie pleurale
Duysinx, B., Corhay, J. L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. E. (2008) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(08)71511-0 · Cited by 2
Picking the winners: Outcome prediction in pleural disease
Corcoran, J. P., & Rahman, N. M. (2018) · Respirology · doi:10.1111/resp.13270 · Cited by 2
Delivery of Talc for Pleurodesis of Malignant Pleural Effusions
Wollbrett, C., Seitlinger, J., & Renaud, S. (2020) · JAMA · doi:10.1001/jama.2020.3265 · Cited by 2
Surgical Procedures Performed in Management of Malignant Pleural Effusions
Laçin, T., & Topçu, S. (2014) · Eurasian Journal of Pulmonology · doi:10.5152/ejp.2014.50133 · Cited by 1
Valchev, D. G., Ilinov, Z., & Obretenov, E. (2017) · Trakia Journal of Sciences · doi:10.15547/tjs.2017.03.004 · Cited by 1
Talc Pleurodesis in Pleural Disease
Marcoux, M., Slate, J., & Majid, A. (2019) · doi:10.33973/pleura31331 · Cited by 1
Aujayeb, A., & Wakefield, D. (2021) · Journal of Respiration · doi:10.3390/jor1020011 · Cited by 1
“Fatigue is a recognized symptom in patients with MPE but has only been studied as part of more global quality of life studies [9,10].”
BackgroundMethodQureshi, M., Thapa, B., & Muruganandan, S. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.02.004 · Cited by 1
Indwelling pleural catheters for the treatment of malignant pleural effusions; where are we now?
Thinnes, W. E., Duke, J. D., Katsis, J. M., & Shojaee, S. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2582248 · Cited by 1
“TP (slurry or poudrage) failure rates increase over time, from 10%−28% at one month, to ~30% at three months, and 28%−50% at six months [22–24].”
Mazzella, A., Degiovanni, S., Mariani, E., Cerretani, G., Bertolaccini, L., Casiraghi, M., Sedda, G., Iacono, G. L., & Spaggiari, L. (2026) · Cancers · doi:10.3390/cancers18111676 · Cited by 1
Management of Malignant Pleural Effusion: Sclerosis or Chronic Tube Drainage
Putnam, J. B. (2007) · Springer eBooks · doi:10.1007/978-1-84628-474-8_51 · Cited by 1
Tecniche Videotoracoscopiche di Induzione Della Pleurodesi
Griffo, S. (2008) · Springer eBooks · doi:10.1007/978-88-470-0522-8_12 · Cited by 1
“Dresler et al. [ 48 ] valutano la comparazione tra talco insufflato in videotoracosopia e il talco “slurry”con una efficacia nei casi di neoplasia del polmone e mammella dell’82 e del 67% rispettivamente, ma con una maggiore incidenza di complicanze respiratorie (14% vs 6%).”
BackgroundIndwelling pleural catheters for malignant pleural effusion
McPhillips, D., & Breen, D. P. (2015) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2015.21.6.266 · Cited by 1
Lee, P. (2012) · CHEST Journal · doi:10.1378/chest.12-1086 · Cited by 1
Derrame pleural maligno: abordagem individualizada conforme apresentação clínica
Junqueira, J. J. M., dos Anjos, D. M., Terra, R. M., & Jatene, F. B. (2007) · Revista de Medicina · doi:10.11606/issn.1679-9836.v86i1p39-51 · Cited by 1
Les pleurésies cancéreuses : traitement local
Jaillard, S. M., Mazières, J., Laroumagne, S., & Guen, P. L. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70383-5 · Cited by 1
Lococo, F., Cesario, A., Meacci, E., Margaritora, S., & Granone, P. M. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.03.103 · Cited by 1
“Moreover, ectopic thymic foci are found inmore thanhalf of cases [5] inwhich an extended thymectomy is performed (a type of operation virtually unfeasible through a non-trans-sternotomic or bilateral transthoracic access).”
BackgroundManagement of Malignant Pleural Effusion: Sclerosis or Chronic Tube Drainage
Kohman, L. J., & Demmy, T. L. (2010) · Springer eBooks · doi:10.1007/978-1-84996-492-0_45 · Cited by 1
Diagnóstico y manejo del derrame pleural maligno
Lezama, M. Á. S., & Martínez-Mendoza, D. (2006) · Acta Médica Grupo Ángeles · Cited by 1
Medical Thoracoscopy in the Management of Malignant Pleural Effusion
Yıldırım, H. (2013) · Solunum · doi:10.5152/solunum.2013.014 · Cited by 1
Wilczynska, M. M. (2015) · International Journal of Respiratory and Pulmonary Medicine · doi:10.23937/2378-3516/1410022 · Cited by 1
“Int J Respir Pulm Med 2015, 2:3 have shown no significant difference in the 30 day pleurodesis success rate (radiologically measured) between surgical (thoracoscopic) talc insufflation and thoracostomy with talc slurry for patients with documented MPE [5,6].”
BackgroundGorensek, B., Schmid, R. A., & Hoksch, B. (2017) · Journal of Clinical Trials · doi:10.4172/2167-0870.1000297 · Cited by 1
“The longer the patient survives, the higher is the chance of treatment failure [5].”
BackgroundMethodInfluentialLázaro, J., Carrasco, V. M., Cases, E., & González, C. G. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.02.009 · Cited by 1
Padilla, F. N. A., Schiavoni, E. N., & Bustos, M. E. F. (2017) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v74.n4.17017 · Cited by 1
Fashoyin‐Aje, L. A., & Brahmer, J. R. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00054-0 · Cited by 1
Mytinger, A., Taylor, T. M., Gershman, E., & Shojaee, S. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0599rr · Cited by 1
Loddenkemper, R., & Janssen, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00024-5 · Cited by 1
Abdelghany, M. F., Essmat, K., Alkarn, A. F., & Youssif, S. F. (2022) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ecdt.ecdt_10_21 · Cited by 1
Management of Malignant Pleural Effusions
Jiménez, C. A., & Shannon, V. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-22610-6_33 · Cited by 1
POCUS-Guided Assessment and Drainage of Pleural Effusion
Mayer, N., & Dalal, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-29472-3_27 · Cited by 1
Patient-Reported Outcomes in Pleural Effusions: A Systematic Review
Mishra, E. K., & Stanton, A. E. (2024) · Cureus · doi:10.7759/cureus.52430 · Cited by 1
Lin, J., Chaddha, U., Urrutia-Royo, B., Ravikumar, N., Bhavani, S. V., Katsis, J. M., Ferguson, M. K., & Murgu, S. D. (2025) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000001007 · Cited by 1
Chen, Z., Li, Y., Zhao, Y., Heng, Z., He, B., Wang, C., Bai, H., Zhao, R., Feng, J., & Zhang, G. (2025) · Journal of Food Biochemistry · doi:10.1155/jfbc/9949812 · Cited by 1
Pleura, Chest Wall, Lung, and Mediastinum
Jurisevic, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-53709-7_19 · Cited by 1
“A signifi cant number of patients, however, die within 30 days of a procedure aimed at effecting a pleurodesis [ 3 , 4 ], and accordingly, the treating surgeon must use all the information at hand to select the patients who will benefi t from such treatment.”
BackgroundDöngel, İ. (2012) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2012.112 · Cited by 1
Thoracoscopy under local anesthesia for patients with a high cardiopulmonary risk index
Yüncü, G. (2012) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2012.104 · Cited by 1
“Thoracoscopy provided effective pleurodesis in 78-82% of patients[14] with a morbidity rate of 3-26% and a mortality rate of less than 1%.”
Medical thoracoscopy at 105. Anniversary
Metintaş, M. (2015) · Eurasian Journal of Pulmonology · doi:10.5152/ejp.2015.47550 · Cited by 1
“Some health centers suggest that pleurodesis with MT is more efficient than pleurodesis performed with the slurry method through a chest tube (41).”
MethodMalignant Pleural Effusions—Personalised Management
Ahmed, M., & Wrightson, J. (2018) · Current Geriatrics Reports · doi:10.1007/s13670-018-0246-0 · Cited by 1
Tunneled Pleural Catheter: Treatment for Recurrent Pleural Effusion
Miller, C. E., Bridges, E. J., Laxmanan, B., Cox‐North, P., & Thompson, H. J. (2018) · AACN Advanced Critical Care · doi:10.4037/aacnacc2018806 · Cited by 1
Campbell, T. C., & Roenn, J. H. V. (2007) · Elsevier eBooks · doi:10.1016/b978-141602597-9.10021-3 · Cited by 1
MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
Ugalde, P. A., Bennett, W. F., & Deslauriers, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06861-4.50095-2 · Cited by 1
Ke, H., Kao, S. C.-H., Lee, K. M. L., Takahashi, K., Goh, H. P., & Linton, A. (2021) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13611 · Cited by 1
Role of LENT Score in Prognosis of Malignant Pleural Effusions
Devi, Y. G., Koyyana, P., Nookaraju, V., Padmaja, B., Mounika, P., & Alekya, P. (2022) · Indian Journal of Respiratory Care · doi:10.4103/ijrc.ijrc_119_21 · Cited by 1
Amarante, M. P. F., Younes, R. N., Rigo, L., & Cruz, M. R. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.452 · Cited by 1
“The first is at least as effective, and in some studies, significantly more effective than the latter [14].”
Background5.2 Mésothéliome pleural malin: Prise en charge de la dyspnée
Greillier, L., & Fraticelli, A. (2006) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(06)71790-9 · Cited by 1
Interactive Physiology Grand Rounds
Schwartzstein, R. M., & Parker, M. J. (2009) · CHEST Journal · doi:10.1378/chest.08-2576 · Cited by 1
Módulo pleuroscopía Patología pleural: Toracoscopía y videotoracoscopía
Clavero, J. M. (2008) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482008000100005 · Cited by 1
Delivery of Talc for Pleurodesis of Malignant Pleural Effusions—Reply
Bhatnagar, R., & Maskell, N. A. (2020) · JAMA · doi:10.1001/jama.2020.3268 · Cited by 1
van Meerbeeck, J. P., & Bottomley, A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.4426 · Cited by 1
Indwelling pleural catheter for malignant pleural effusion – Are we ready?
Patel, D. D., & Banka, R. A. (2022) · Lung India · doi:10.4103/lungindia.lungindia_412_22 · Cited by 1
“While pleurodesis requires hospitalisation and has an approximately 50% failure rate at six months,[4] it remains the first procedure of choice in our country mainly due to the ease of administration, patient preference and its favourable economics.”
BackgroundShannon, V. R., Eapen, G. A., Jiménez, C. A., Grosu, H. B., Morice, R. C., Bashoura, L., Sheshadre, A., Evans, S. E., Adachi, R., Kroll, M. H., et al. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm134.pub2 · Cited by 1
Sootlek, J. (2022) · doi:10.58837/chula.the.2022.248 · Cited by 1
“Patients reported a better quality of life and improved comfort levels after pleurodesis, although no significant differences were observed((38)).”
BackgroundManagement of Malignant Pleural Effusion
DeMarco, B., & MacRosty, C. R. (2023) · Respiratory medicine · doi:10.1007/978-3-031-38412-7_10 · Cited by 1
Minimally Invasive Approaches to Lung Cancer
Mason, D. P., Murthy, S. C., Su, J. W., & Rice, T. W. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1238-1_21
“However, VATS talc pleurodesis was found to be no more effective in palliation of malignant pleural effusions than bedside talc instillation via a chest tube [ 60 ].”
Talkumpleurodese mittels internistischer Thorakoskopie beim malignen oder chronischen Pleuraerguss
Gillissen, A., & Kellner, S. (2010) · Der Pneumologe · doi:10.1007/s10405-009-0391-4
Complications of Talc Poudrage in the United States
Aelony, Y. (2011) · CHEST Journal · doi:10.1378/chest.10-2267
Symphyse pleurale : quelle technique pour quelle indication ?
Fraticelli, A., & Scherpereel, A. (2007) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(07)91803-3
MALIGN PLEVRAL EFUZYONLARIN TEDAVISI: BRITANYA TORAKS DERNEGI PLEVRAL HASTALIKLAR REHBERI 2010
Roberts, M. E., Neville, E., Berrisford, R. G., Antunes, G., & Ali, N. J. (2011) · Plevra Bulteni · doi:10.5152/pb.2011.04
Diagnóstico y tratamiento de la pleuritis
Astoul, P. J. (2008) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(08)70592-0
CURRENT MANAGEMENT OF PLEURAL DISORDERS
Kastelik (2013) · Current Research in Medicine · doi:10.3844/amjsp.2013.110.121
“Talc is the most effective chemical pleurodesis agent and has been shown to be safe and effective treatment of malignant pleural effusion (Dresler et al., 2005; Janssen et al., 2007).”
BackgroundAbord de l’épanchement pleural métastatique symptomatique cas clinique interactif
Astoul, P. J. (2014) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(14)70606-8
Sheski, F. D., & Mathur, P. N. (2006) · Journal of Bronchology · doi:10.1097/01.lbr.0000212562.68274.ed
Cas clinique n° 6 Cancer métastatique
Léna, H., Héry, G., & Jouneau, S. (2015) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(15)30013-6
Stefani, A., Natali, P., Casali, C., & Morandi, U. (2007) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2007.05.006
Srour, N. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-5064
Management of Recurrent Pleurisies by Thoracoscopy
Herth, F. J. F. (2013) · Springer eBooks · doi:10.1007/978-3-642-38351-9_14
Lung Cancer Coexisting With Ipsilateral Pleural Effusion
Rodríguez‐Panadero, F., & Romero‐Romero, B. (2014) · Lung Cancer Management · doi:10.2217/lmt.14.21
McKenna, S. S. (2011) · Springer eBooks · doi:10.1007/978-0-387-88493-6_25
Gestione chirurgica dei tumori pleurici primitivi e secondari (a eccezione del mesotelioma)
Rivera, C., Pricopi, C., Pimpec‐Barthes, F. L., & Riquet, M. (2015) · EMC - Tecniche Chirurgiche Torace · doi:10.1016/s1288-3336(15)70703-x
Contribution à l'étude de la pathologie pleurale maligne.
Duysinx, B. (2009) · ORBi (University of Liège)
Tumeurs secondaires de la plèvre Diagnostic, traitement local
Girard, P. (2011) · Springer eBooks · doi:10.1007/978-2-287-99041-0_21
Pleurésies néoplasiques : diagnostic et principes de prise en charge
Girard, P., Gossot, D., & Caliandro, R. (2010) · Encyclopédie médico-chirurgicale. Pneumologie · doi:10.1016/s1155-195x(10)48015-9
Démarche diagnostique et thérapeutique devant une pleurésie
Astoul, P. J. (2008) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(08)34167-2
Efficacy of 50% glucose pleurodesis
Fujino, K., Kubota, I., Motooka, Y., Ikeda, K., Mori, T., & Suzuki, M. (2013) · The Journal of the Japanese Association for Chest Surgery · doi:10.2995/jacsurg.27.670
Prise en charge symptomatique des pleurésies malignes
Scherpereel, A. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70412-9
LOKAL ANESTEZI ILE YAPILAN TORAKOSKOPI: BRITANYA TORAKS DERNEGI PLEVRAL HASTALIKLAR REHBERI 2010
Rahman, N. M., Ali, N. J., Brown, G., Chapman, S. J., Davies, R. J. O., Downer, N. J., Gleeson, F. V., Howes, T. Q., Treasure, T., Singh, S., et al. (2011) · Plevra Bulteni · doi:10.5152/pb.2011.06
Campbell, T. C., & Roenn, J. H. V. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1619-1.00025-1
45of Malignant Pleural Effusion: Sclerosis or Chronic Tube Drainage
Kohman, L. J., & Demmy, T. L. (2011)
Randomized Controlled Trials and 21st Century Epistemology
Grannis, F. W. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0095
Hunt, B. M., Farivar, A. S., Vallières, E., Louie, B. E., Aye, R. W., Flores, E. E., & Gorden, J. A. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.06.042
“Dressler and associates [5], in the Intergroup trial, report a pleurodesis failure rate of 32% by talc slurry and 27% by talc insufflation.”
BackgroundDavies, H. E., Thomas, R., Francis, R. J., & Lee, G. (2014) · Respirology · doi:10.1111/resp.12446
Pleural and Peritoneal Catheters
Pawlik, T. M., & Sherwood, J. T. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05674-8.50104-3
Pleural and pericardial effusions
Balmanoukian, A. S., & Brahmer, J. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1015-1.00032-1
Daniel, E. O. (2016) · TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH · doi:10.21522/tijcr.2014.03.01.art025
Thoracic Emergencies: Tracheobronchial, Pulmonary, and Pleural Diseases
Erhunmwunsee, L., & Raz, D. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-44025-5_8
Mehta, D. K., Bali, S., Dagar, A., & Utaal, M. S. (2016) · International Journal of Scientific Reports · doi:10.18203/issn.2454-2156.intjscirep20164839
Guinde, J., Habert, P., Martinez, S., Tazi, R., Laroumagne, S., Astoul, P. J., & Dutau, H. L. (2014) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(14)70009-6
Management of Recurrent Malignant Pleural Effusions: Response
Lee, P. (2012) · CHEST Journal · doi:10.1378/chest.12-2252
Complications of Talc Poudrage in the United States: Response
Gonzalez, A. V., Bezwada, V., Beamis, J. F., & Villanueva, A. G. (2011) · CHEST Journal · doi:10.1378/chest.10-2737
Effect of chest tube position on the success rate of pleurodesis: A retrospective cohort study
Takemura, T., Ikegaki, S., Saito, E., Matsumoto, H., Shinomiya, M., & Kataoka, Y. (2017) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2017.08.005
Malignant Pleural Efusions: Diagnosis and Treatment
Çobanoğlu, U., Kızıltan, R., & Kemik, Ö. (2017) · Van Medical Journal · doi:10.5505/vtd.2017.96967
Kastelik, J. A., Greenstone, M. A., & Pathmanathan, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-94127-1_7
Metadata
- Authors
- Dresler, C. M., Olak, J., Herndon, J. E., Richards, W. G., Scalzetti, E., Fleishman, S. B., Kernstine, K. H., Demmy, T., Jablons, D. M., Kohman, L., Daniel, T. M., Haasler, G. B., & Sugarbaker, D. J.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- Advocate Lutheran General Hospital (US)
- Brigham and Women's Hospital (US)
- SUNY Upstate Medical University (US)
- University of Iowa (US)
- Roswell Park Comprehensive Cancer Center (US)
- University of California, San Francisco (US)
- University of Virginia Health System (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Dresler, Carolyn M
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 127
- Issue
- 3
- Pages
- 909-915
- ISSN
- 0012-3692 (ISSN-L)
- PMC
- PMC4644736
- OpenAlex
- W2147481343
- Cited by
- 578
- References
- 39
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 24 · 2023: 12 · 2022: 27 · 2021: 26 · 2020: 40 · 2019: 23 · 2018: 38 · 2017: 31 · 2016: 32 · 2015: 34 · 2014: 32 · 2013: 33 · 2012: 35
- FWCI
- 22.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (2 U01 CA65170, R01CA093708, U01CA065170)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pleural and Pulmonary Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Pericarditis and Cardiac Tamponade
- Keywords
- malignant pleural effusion, talc poudrage, talc slurry, talc pleurodesis, thoracostomy, pleural effusion recurrence, respiratory complications, non-relapse mortality, quality of life, lung cancer, breast cancer
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Insufflation, Male, Middle Aged, Quality of Life, Recurrence, Talc, Thoracoscopy, Thoracostomy, Pleural Effusion, Malignant, Pleurodesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
